Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.
about
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
P2860
Targeting triglycerides as prognostic indicators and determining lowest values for patient benefit.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Targeting triglycerides as pro ...... st values for patient benefit.
@ast
Targeting triglycerides as pro ...... st values for patient benefit.
@en
Targeting triglycerides as pro ...... st values for patient benefit.
@nl
type
label
Targeting triglycerides as pro ...... st values for patient benefit.
@ast
Targeting triglycerides as pro ...... st values for patient benefit.
@en
Targeting triglycerides as pro ...... st values for patient benefit.
@nl
prefLabel
Targeting triglycerides as pro ...... st values for patient benefit.
@ast
Targeting triglycerides as pro ...... st values for patient benefit.
@en
Targeting triglycerides as pro ...... st values for patient benefit.
@nl
P2860
P1476
Targeting triglycerides as pro ...... st values for patient benefit.
@en
P2093
Sprecher DL
P2860
P2888
P304
P356
10.1007/S11886-001-0060-7
P577
2001-09-01T00:00:00Z
P6179
1017744403